BioSpace News Archive

Deals

Viking Therapeutics Announces Closing of Public Offering of 8,625,000 Shares of Common Stock

Viking Therapeutics, Inc. announced the closing of its previously announced underwritten public offering of 8,625,000 shares of its common stock

June 12, 2018
·
5 min read
Biotech Beach

Dexcom G6® CGM System Receives CE Mark

Revolutionary new CGM system eliminates routine fingersticks for people with diabetes and is nearly one-third smaller than previous generation

June 12, 2018
·
4 min read
Business

Arcus Biosciences Announces the Promotion of Jennifer Jarrett to Chief Operating Officer

Ms. Jarrett will be responsible for several key areas, including finance, investor relations, corporate communications, business and corporate development, strategic planning and human resources.

June 12, 2018
·
4 min read
BioMidwest

Kraig Biocraft Laboratories Deploys New Spider Silk DNA Synthesis Methodology

More than 2,500 test microinjections completed with expanded lab staff to boost throughput

June 12, 2018
·
3 min read
Business

Finch Therapeutics Expands Senior Leadership Team with Appointments of Dr. Ulrich Thienel as Chief Medical Officer and Gregory Perry as Chief Financial Officer

Dr. Thienel will lead the clinical development of Finch’s Full-Spectrum Microbiota™ and Rationally-Selected Microbiota™ platforms, while Mr. Perry will provide strategic financial and operational leadership at Finch.

June 12, 2018
·
4 min read
Pharm Country

Pfizer Announces Extension of Zithromax® Antibiotic Donation Program through 2025 to Help Eliminate World’s Leading Infectious Cause of Blindness

Pfizer Inc. announced today it will extend its donation of the antibiotic Zithromax® (azithromycin) to the International Trachoma Initiative through 2025.

June 12, 2018
·
8 min read
RTI Surgical® Announces Commercial Launch of Fortilink®-TS and -L IBF Systems with TETRAfuse® 3D Technology

RTI Surgical, Inc. announced the full commercial launch of its Fortilink®-TS and -L IBF Systems, adding to a growing series of interbody fusion devices featuring proprietary TETRAfuse® 3D Technology.

June 12, 2018
·
7 min read
Drug Development

Galmed’s 600 mg Aramchol™ Achieved a Regulatory Approvable Endpoint Showing NASH Resolution Without Worsening of Fibrosis, in NASH Patients, in the Global Phase 2b ARREST 52-Week Study

Data Strongly Support Advancement of Aramchol™ 600mg to Phase

June 12, 2018
·
14 min read
Business

CytoSorbents Officially Opens New U.S. CytoSorb Manufacturing Facility

New facility quadruples production capacity and is expected to accelerate margin expansion and drive operating profitability

June 12, 2018
·
4 min read
BioMidwest

Vodori Announces Smart Reference Linking Capability for Promotional Review Process

Text recognition to suggest reference links, significantly reducing job preparation time

June 12, 2018
·
2 min read